Wiley.com

User login

Study Points to a Growing Trend in Opioid Use Over the Past Two Decades 


The prevalence of prescription opioid use increased from 4.1% of US adults in 19992000 to 6.8% in 20132014, according to a recent Pharmacoepidemiology and Drug Safety study.

Thursday, September 7, 2017 12:01 am EDT
"The sharply increasing trend in long-term use of prescription opioids is somewhat concerning because there is little research on the possible benefits of this form of treatment—whereas, the evidence about the negative health effects of long-term use of these medications is growing"

The prevalence of prescription opioid use increased from 4.1% of US adults in 19992000 to 6.8% in 20132014, according to a recent Pharmacoepidemiology and Drug Safety study.

 

This trend was driven by a sharp increase in longterm use which increased from 1.8% to 5.4%. Of all opioid users in 20132014, 79.4% were longterm users compared with 45.1% in 19992000. Longterm use was associated with poorer physical health, concurrent benzodiazepine use, and history of heroin use.

 

The study included data from 47,356 adult participants of National Health and Nutrition Survey from 19992000 to 20132014.

 

“The sharply increasing trend in long-term use of prescription opioids is somewhat concerning because there is little research on the possible benefits of this form of treatment—whereas, the evidence about the negative health effects of long-term use of these medications is growing,” said Dr. Ramin Mojtabai, author of the study.


Additional Information


Link to Study: http://onlinelibrary.wiley.com/doi/10.1002/pds.4278/full

About Journal

The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report.    

Multimedia Files:

Preview image

Contact:

Penny Smith
Tel: +44 (0)1243 770448
sciencenewsroom@wiley.com